High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy
M Legendre, K Onel, L Zhao, Y Kimura, S Prahalad, Barbara Adams, David Markovitz, J Mehta, S Mohan, LK Jung, EH Giannini, B Huang, JC Olson, MH Passo, SJ Spalding, T Mau, Y Yuanfan, PW Morris, T Beukelman, M Rivas, EA Cassidy, BS Gottlieb, A Johnson, M Shishov, DJ Lovell, BS Edelheit, N Mor-Vaknin
DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis
DA Pai, Jason Knight, J Jorns, C Carmona-Rivera, Mor-Vaknin, Mohammad Amin, S Yalavarthi, David Engelke, A Saha, SJ Almburg, S Mohan, K Angevine, AE Koch, MJ Kaplan, David Fox, MJ Gonzales-Hernandez, BJ Rabquer, M Legendre, Barbara Adams, David Markovitz
Intercellular trafficking of the nuclear oncoprotein DEK
DM Rosmarin, David Markovitz, A Mundade, , E Ferrando-May, A Deutzmann, AK Saha, N Chatain, M Legendre, Z Al-Obaidi, Barbara Adams, F Kappes, HL Ploegh
Load more…